Northern Trust’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$120K Sell
167,734
-466,189
-74% -$333K ﹤0.01% 4073
2025
Q1
$412K Sell
633,923
-2,997
-0.5% -$1.95K ﹤0.01% 3651
2024
Q4
$1.17M Buy
636,920
+14,492
+2% +$26.7K ﹤0.01% 3319
2024
Q3
$2.15M Buy
622,428
+119,780
+24% +$414K ﹤0.01% 2957
2024
Q2
$1.47M Buy
502,648
+16,264
+3% +$47.7K ﹤0.01% 3070
2024
Q1
$2.75M Buy
486,384
+5,200
+1% +$29.4K ﹤0.01% 2797
2023
Q4
$2.06M Sell
481,184
-4,638
-1% -$19.9K ﹤0.01% 2991
2023
Q3
$1.69M Buy
485,822
+2,750
+0.6% +$9.54K ﹤0.01% 3031
2023
Q2
$2.25M Buy
483,072
+28,165
+6% +$131K ﹤0.01% 2944
2023
Q1
$2.1M Sell
454,907
-5,656
-1% -$26.1K ﹤0.01% 2918
2022
Q4
$3.72M Buy
460,563
+53,791
+13% +$435K ﹤0.01% 2664
2022
Q3
$2.26M Buy
406,772
+29,792
+8% +$165K ﹤0.01% 2955
2022
Q2
$1.96M Sell
376,980
-14,044
-4% -$73.2K ﹤0.01% 3079
2022
Q1
$3.21M Sell
391,024
-154,200
-28% -$1.27M ﹤0.01% 2846
2021
Q4
$8.11M Buy
545,224
+9,200
+2% +$137K ﹤0.01% 2384
2021
Q3
$10.1M Sell
536,024
-18,375
-3% -$347K ﹤0.01% 2258
2021
Q2
$10.3M Buy
554,399
+210,078
+61% +$3.91M ﹤0.01% 2339
2021
Q1
$7.84M Buy
344,321
+30,045
+10% +$684K ﹤0.01% 2461
2020
Q4
$6.82M Buy
314,276
+93,467
+42% +$2.03M ﹤0.01% 2490
2020
Q3
$2.22M Buy
220,809
+1,659
+0.8% +$16.7K ﹤0.01% 3015
2020
Q2
$1.7M Buy
219,150
+91,468
+72% +$710K ﹤0.01% 3120
2020
Q1
$1.3M Buy
127,682
+5,502
+5% +$56.1K ﹤0.01% 3083
2019
Q4
$1.34M Buy
122,180
+756
+0.6% +$8.32K ﹤0.01% 3297
2019
Q3
$1.1M Buy
121,424
+41,647
+52% +$378K ﹤0.01% 3363
2019
Q2
$907K Buy
79,777
+4,910
+7% +$55.8K ﹤0.01% 3391
2019
Q1
$852K Buy
74,867
+10,551
+16% +$120K ﹤0.01% 3411
2018
Q4
$580K Buy
+64,316
New +$580K ﹤0.01% 3519